Chi DS - Search Results

1

A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection.

Tian WJ, Chi DS, Sehouli J, Tropé CG, Jiang R, Ayhan A, Cormio G, Xing Y, Breitbach GP, Braicu EI, Rabbitt CA, Oksefjell H, Fotopoulou C, Meerpohl HG, du Bois A, Berek JS, Zang RY, Harter P. Tian WJ, et al. Among authors: chi ds. Ann Surg Oncol. 2012 Feb;19(2):597-604. doi: 10.1245/s10434-011-1873-2. Epub 2011 Jul 6. Ann Surg Oncol. 2012. PMID: 21732142

2

The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery.

Boente MP, Chi DS, Hoskins WJ. Boente MP, et al. Among authors: chi ds. Semin Oncol. 1998 Jun;25(3):326-34. Semin Oncol. 1998. PMID: 9633844 Review.

3

Splenectomy in recurrent epithelial ovarian cancer.

Gemignani ML, Chi DS, Gurin CC, Curtin JP, Barakat RR. Gemignani ML, et al. Among authors: chi ds. Gynecol Oncol. 1999 Mar;72(3):407-10. doi: 10.1006/gyno.1998.5141. Gynecol Oncol. 1999. PMID: 10053114 Review.

4

The role of laparoscopy in second-look evaluations for ovarian cancer.

Husain A, Chi DS, Prasad M, Abu-Rustum N, Barakat RR, Brown CL, Poynor EA, Hoskins WJ, Curtin JP. Husain A, et al. Among authors: chi ds. Gynecol Oncol. 2001 Jan;80(1):44-7. doi: 10.1006/gyno.2000.6036. Gynecol Oncol. 2001. PMID: 11136568

5

Advanced ovarian cancer.

Chi DS, Sabbatini P. Chi DS, et al. Curr Treat Options Oncol. 2000 Jun;1(2):139-46. doi: 10.1007/s11864-000-0058-1. Curr Treat Options Oncol. 2000. PMID: 12057051 Review.

6

Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series.

Pothuri B, Vaidya A, Aghajanian C, Venkatraman E, Barakat RR, Chi DS. Pothuri B, et al. Among authors: chi ds. Gynecol Oncol. 2003 May;89(2):306-13. doi: 10.1016/s0090-8258(03)00073-8. Gynecol Oncol. 2003. PMID: 12713996

7

Resection of recurrent ovarian or fallopian tube carcinoma involving the liver.

Yoon SS, Jarnagin WR, Fong Y, DeMatteo RP, Barakat RR, Blumgart LH, Chi DS. Yoon SS, et al. Among authors: chi ds. Gynecol Oncol. 2003 Nov;91(2):383-8. doi: 10.1016/j.ygyno.2003.07.005. Gynecol Oncol. 2003. PMID: 14599870

8

Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy.

Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, Yu MC, Zempolich K, Dubeau L. Nouriani M, et al. Among authors: chi ds. Clin Cancer Res. 2004 Apr 15;10(8):2681-6. doi: 10.1158/1078-0432.ccr-0523-03. Clin Cancer Res. 2004. PMID: 15102671

9

Tertiary cytoreduction in patients with recurrent ovarian carcinoma.

Leitao MM Jr, Kardos S, Barakat RR, Chi DS. Leitao MM Jr, et al. Among authors: chi ds. Gynecol Oncol. 2004 Oct;95(1):181-8. doi: 10.1016/j.ygyno.2004.07.033. Gynecol Oncol. 2004. PMID: 15385129

10

Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.

Pothuri B, Meyer L, Gerardi M, Barakat RR, Chi DS. Pothuri B, et al. Among authors: chi ds. Gynecol Oncol. 2004 Oct;95(1):193-5. doi: 10.1016/j.ygyno.2004.07.028. Gynecol Oncol. 2004. PMID: 15385131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters